Eight-year-old Ralfi Noble is again a picture of health after battling back from a rare form of cancer.
He endured 24 weeks of chemotheraphy during which he lost all his hair and three stones in weight.
But, he is now in remission and back in the classroom at Burnley Road Academy, Mytholmroyd.
Parents Nicola and Jason Noble and her friend Julie Martin have now organised a fundraising afternoon tomorrow to say thanks to the Candlelighters charity which helped them through the ordeal.
Nicola said Ralfi developed a lump in a testicle in August 2012 and it was found to be rhabdomysarcoma which only affects 35 children in the UK annually.
It’s a tumour which attacks soft tissue and can develop in other parts of the body.
Every Friday Ralfi was taken to Leeds General Infirmary for treatment.
“It was awful time. He very rarely went to school and he was so sick we carried him out of the house in a quilt,” said Nicola.
“I did not realise how tough it would be.”
Ralfi was said to be in remission in March this year and will have full check-ups every three months for the next five years.
Nicola said the worst time was at the beginning when loved ones were rocked with the news and had to wait for an agonising 10 days to learn the result of tests.
Fortunately, the cancer hadn’t spread elsewhere.
She said hospital staff were great and the children’s charity Candlelighters was so supportive the family wanted to give something back.
Nicola, intended holding an afternoon tea at the family home at Tuel Lane, Sowerby Bridge, but interest swelled.
Consequently, tomorrow from noon to 3 pm over 15 stalls, Santa, a snow machine, and a tombola and auction with numerous prizes from given by businesses will fill St Paul’s Church, Sowerby Bridge, and everyone is welcome to attend.
“Everybody has been so supportive and that is great,” said Nicola.
Candlelighters was formed more than 40 years ago and is run by parents of children who have or have had cancer and the medical staff who treat them. It helps support families with counselling, help on hospital wards and funds research into new treatments.